Cognition Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	31.23	37	25.01	29.92	41.56	54.72
Cash & Short-Term Investments	31.23	37	25.01	29.92	41.56	54.72
Cash Growth	90.07%	47.95%	-16.42%	-28.01%	-24.05%	954.56%
Other Receivables	3.66	9.92	2.69	1.28	3.67	2.27
Total Trade Receivables	3.66	9.92	2.69	1.28	3.67	2.27
Other Current Assets	0.93	1.07	1.86	3.02	2.41	2.01
Total Current Assets	35.81	47.99	29.56	34.22	47.65	58.99
Net Property, Plant & Equipment	0.33	0.4	0.68	0.94	1.05	0.15
Other Long-Term Assets	-	-	-	-	1.73	-
Total Assets	36.14	48.39	30.23	35.16	50.43	59.14
Accounts Payable	3.85	1.12	1.98	3.7	3.22	4.17
Accrued Expenses	1.69	12	7.62	4.06	2.09	1.75
Current Portion of Leases	0.1	0.14	0.19	0.17	0.15	-
Unearned Revenue	0.22	0.37	1.07	1.7	1.7	0.75
Other Current Liabilities	0.19	0.31	0.28	0.54	0.63	1.19
Total Current Liabilities	6.05	13.92	11.14	10.17	7.8	7.86
Long-Term Leases	0.18	0.2	0.34	0.52	0.7	-
Other Long-Term Liabilities	-	-	-	-	1.69	-
Total Long-Term Liabilities	0.18	0.2	0.34	0.52	2.38	-
Total Liabilities	6.23	14.12	11.48	10.69	10.18	7.86
Common Stock	0.09	0.09	0.06	0.03	0.03	0.02
Additional Paid-in Capital	233.04	232.83	193.85	165.83	155.82	145.45
Accumulated Other Comprehensive Income	-	-	-	-0.2	-0.2	-0.2
Retained Earnings	-203.22	-198.65	-175.16	-141.19	-115.4	-94
Total Common Shareholders' Equity	29.91	34.27	18.75	24.47	40.25	51.27
Shareholders' Equity	29.91	34.27	18.75	24.47	40.25	51.27
Total Liabilities & Equity	36.14	48.39	30.23	35.16	50.43	59.14
Total Debt	0.27	0.33	0.54	0.69	0.84	0
Net Cash (Debt)	30.95	36.67	24.47	29.23	40.72	54.72
Net Cash Growth	-15.58%	49.83%	-16.27%	-28.22%	-25.59%	-
Net Cash Per Share	0.39	0.50	0.62	0.97	1.72	10.54
Book Value	29.91	34.27	18.75	24.47	40.25	51.27
Book Value Per Share	0.37	0.47	0.47	0.82	1.70	9.88
Tangible Book Value	29.91	34.27	18.75	24.47	40.25	51.27
Tangible Book Value Per Share	0.37	0.47	0.47	0.82	1.70	9.88

Updated May 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q